Seystahl, K., Stoecklein, V., Schüller, U., Rushing, E., Nicolas, G., Schäfer, N., . . . Albert, N. L. (2016). Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: Benefit linked to (68)Ga-DOTATATE/-TOC uptake. Neuro Oncol.
Chicago Style CitationSeystahl, Katharina, et al. "Somatostatin Receptor-targeted Radionuclide Therapy for Progressive Meningioma: Benefit Linked to (68)Ga-DOTATATE/-TOC Uptake." Neuro Oncol 2016.
Cita MLASeystahl, Katharina, et al. "Somatostatin Receptor-targeted Radionuclide Therapy for Progressive Meningioma: Benefit Linked to (68)Ga-DOTATATE/-TOC Uptake." Neuro Oncol 2016.
Atenció: Aquestes cites poden no estar 100% correctes.